{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:22:58Z","timestamp":1773282178189,"version":"3.50.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,7,9]],"date-time":"2004-07-09T00:00:00Z","timestamp":1089331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1038\/sj.eye.6701441","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T08:43:28Z","timestamp":1089881008000},"page":"129-137","source":"Crossref","is-referenced-by-count":40,"title":["Alphagan allergy may increase the propensity for multiple eye-drop allergy"],"prefix":"10.1038","volume":"19","author":[{"given":"S A","family":"Osborne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D M I","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I C","family":"McKay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,7,9]]},"reference":[{"issue":"5","key":"BF6701441_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1006\/exer.1996.0267","volume":"64","author":"CD Thompson","year":"1997","unstructured":"Thompson CD, Macdonald TL, Garst ME, Weise A, Munk SA . Mechanisms of adrenergic agonist induced allergy bioactivation and antigen formation. Exp Eye Res 1997; 64(5): 767\u2013773.","journal-title":"Exp Eye Res"},{"issue":"2","key":"BF6701441_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/PL00007883","volume":"238","author":"O Geyer","year":"2000","unstructured":"Geyer O, Schmidt KG, Pianka P, Neudorfer M, Lazar M . Clonidine provides an allergy-free alternative in glaucoma patients with proven allergy to apraclonidine. Graefes Arch Clin Exp Ophthalmol 2000; 238(2): 149\u2013152.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"BF6701441_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00061198-200006000-00006","volume":"9","author":"GC Williams","year":"2000","unstructured":"Williams GC, Orengo-Nania S, Gross RL . Incidence of brimonidine allergy in patients previously allergic to apraclonidine. J Glaucoma 2000; 9(3): 235\u2013238.","journal-title":"J Glaucoma"},{"issue":"5","key":"BF6701441_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S0002-9394(98)00450-4","volume":"127","author":"DH Shin","year":"1999","unstructured":"Shin DH, Glover BK, Cha SC, Kim YY, Kim C, Nguyen KD . Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy. Am J Ophthalmol 1999; 127(5): 511\u2013515.","journal-title":"Am J Ophthalmol"},{"issue":"Part 4","key":"BF6701441_CR5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/eye.1998.171","volume":"12","author":"RN Gordon","year":"1998","unstructured":"Gordon RN, Liebmann JM, Greenfield DS, Lama P, Ritch R . Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy. Eye 1998; 12(Part 4): 697\u2013700.","journal-title":"Eye"},{"key":"BF6701441_CR6","first-page":"293","volume":"1995","author":"P Butler","year":"19113","unstructured":"Butler P, Mannschreck M, Lin S, Hwang I, Alvarado J . Clinical experience with the long-term use of 1% apraclonidine. Arch Ophthalmol 113; 1995: 293\u2013296.","journal-title":"Arch Ophthalmol"},{"key":"BF6701441_CR7","first-page":"267","volume":"88","author":"JA Alvarado","year":"1990","unstructured":"Alvarado JA, Franse-Carman L, McHolm G, Murphy C . Epinephrine effects on major cell types of the aqueous outflow pathway: in vitro studies\/clinical implications. Trans Am Ophthalmol Soc 1990; 88: 267\u2013282.","journal-title":"Trans Am Ophthalmol Soc"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701441","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:16:49Z","timestamp":1684412209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,9]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["BF6701441"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701441","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,9]]}}}